fbpx

Congratulations to the MedTech Actuator Origin 2022 Finalists!

Out of thirteen impressive startups that made it to the Origin Semi-final, MedTech Actuator is proud to announce four finalists moving forward to pitch at the MedTech Actuator Showcase in December.

After three days of intensive workshops, 10 emerging founders took to the stage to pitch in the 2022 MedTech Actuator Origin Semi-finals. Amongst the Australian founders, three Semi-Finalists from Origin Japan also joined the program in Melbourne, where they learned from industry experts, pressure-tested their innovations, and explored Australia’s startup ecosystem. 

Tackling some of the biggest challenges in healthcare, Finalists are innovating across dental, IVF, itching and endometriosis. Meet the MedTech Actuator Origin 2022 Finalists:

AcuDent

Team members: Liam Murray, Aaron Binns, Anna Dai, Ashwin Ho, Ivy Weng 

AcuDent is developing a medical device to revolutionise the detection of severe gum disease.

AcuDent’s device, the AcuProbe, applies computer vision within the oral environment to more efficiently and accurately conduct the work that current practice burdens the clinician to do manually. The device will ensure that proper diagnosis is achieved to avoid the occurrence of undetected periodontitis, ensuring patients receive the best possible care and dramatically reducing the chances of tooth loosening and tissue degradation – keeping everyone smiling longer.

ENVI 

Team members: Amin Abbas, Nay Minn, Dr Rizwan Jaipurwala, Frederick Lau, Joey Zhou, Steven Wong

ENVI is improving endometriosis imaging by using ultrasound with inbuilt guidance and 3D reconstruction.

ENVI is working on creating a device that can diagnose endometriosis using ultrasound. The device aims to reduce the diagnostic duration for endometriosis. This allows patients to receive an early diagnosis and hence access to early treatment.  Early diagnosis gives patients hope of slowing disease progression and reduces the harmful long-term risks associated with endometriosis, including its association with an increase in cancer risk. It also benefits GPs by reducing multiple patient visits with undifferentiated symptoms, improving the workflow of primary care staff and increasing patient satisfaction. 

Innova IVF

Team members: Dr Fabrizzio Horta, Dr Victor Cadarso, Prof Adrian Neild, Prof Beverley Vollenhoven, A/Prof Sally Catt

Innova IVF is creating simple, affordable chip technology to measure the energy of embryos in real time for IVF treatments.

Innova IVF aims to improve treatments for couples suffering from infertility worldwide. The most critical aspect of IVF treatments relies on the selection of embryos that will lead to a healthy live birth. Thus, the team aims to improve embryo selection by introducing novel non-invasive technology to measure the embryo’s energy in the form of metabolic activity.

Osaka Heat Cool

Team members: Kenzo Ibano, Kiyono Yoshikuni, Toru Sugahara, Kuichi Itoh, Katsunari Sato, Shintaro Izumi 

Osaka Heat Cool helps to tackle the symptoms of Atopic Dermatitis (AD), allergies, and other skin diseases by stopping itchiness using thermal illusion on the skin.

The team is solving the pain caused by itching using thermal illusion on the skin. Using an illusion called the thermal grill illusion, the device provides pain sensation by applying hot and cold sensations simultaneously. This pain sensation does not harm the skin, instead relieves the itch without scratching by nails.

We would like to thank our judges Dr Buzz Palmer, CEO of MedTech Actuator, Lorace Zhang, CEO at Vysum and MedTech Actuator Origin 2021 Winner, Laxmi Pun, Director of Early-stage Investments at Breakthrough Victoria, Shanna Lam, Project Officer at MedTech Actuator, and all community members for attending the MedTech Actuator Origin Semi-final and cheering on startups improving health outcomes.

The MedTech Actuator Origin Final will take place on Thursday, December 1 at the MedTech Actuator Showcase. At the Showcase, teams will have the chance to take home a $10K cash prize, over $5k worth of in-kind support and gain access to fast-tracked entry into MedTech Actuator Accelerator 2023.

What is next?

Preparations are now underway for a night-of-nights celebration at the MedTech Actuator Showcase, where all programs converge and the ecosystem – from across the Asia-Pacific – will come together to applaud the achievements, impact and progress of founders in health innovation. 

The MedTech Actuator Showcase will be held on Thursday, December 1 in Melbourne. If you are interested in purchasing a table or sponsoring a prize for this exclusive event, please reach out to Matthew Frith, Chief Commercial Officer at MedTech Actuator.

Stay in the loop by signing up for our newsletter below to get the latest updates on our programs and upcoming events.

MedTech Actuator Origin is supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.



Announcing MedTech Actuator Origin Japan’s semi-finalists

After three days of working closely with 14 medical startups in Japan, MedTech Actuator is excited to announce three semi-finalists who will join MedTech Actuator Origin in Australia in one month. 

MedTech Actuator Origin Japan – an early-stage innovation program for MedTech, BioTech, and HealthTech startups looking to explore Australia and the Asia-Pacific market – kicked off its first cohort this week, welcoming a diverse range of medical and health innovations that spanned across diagnostic imaging, bioprinting, endoscopy, elderly care and cancer treatments and care.

Emerging founders and entrepreneurs joined MedTech Actuator and partners, JETRO, OCCI, OBDA and industry experts, for a 3-day bootcamp in Osaka. Together, explored the medical startup ecosystems across Australia and Asia-Pacific and learned about pitching their innovations to a global market, commercialisation strategies and more. The program culminated at a Semi-final, where each startup pitched for their chance to come to Australia and join MedTech Actuator Origin in October.

Congratulations to Osaka Heat Cool, Relive and iDevice,Inc.

Judges and industry guests were blown away by the medical innovations and quality of each pitch. Congratulations to the selected semi-finalists:

  • Osaka Heat Cool (Thermo Scratch) | Kenzo Ibano | Osaka Heat Cool helps to tackle the symptoms of Atopic Dermatitis(AD), allergies, and other skin diseases by stopping itchiness using thermal illusion on the skin.
  • Relive (CureMind) | Risa Kaneda,Iizuka Sora, Kubo Tokumi  | CureMind is an online, high-availability, real-time access to cancer support services in a safe environment via a mobile application.
  • iDevice, Inc. | Yuto Kido |  iDevice has created the Javalla mask – a tailor-made ventilation mask that provides comfortable sealing and prevents skin injuries and discomfort.

Next, these Japanese startups will join MedTech Actuator in Melbourne next month for a week-long intensive program, where over five days they’ll learn from industry experts, pressure test their innovations, and network with and pitch to Australia’s startup ecosystem. 

Ultimately, one Japanese startup will be selected to return to Australia to pitch at the MedTech Actuator Showcase – an industry event attended by 300 experts in BioMedical innovation on December 1. At this event, startups will compete for a chance to win a $10K cash prize, over $5k worth of in-kind support, and a fast-tracked entry into MedTech Actuator Accelerator 2023  to accelerate the commercialisation of their ideas.

MedTech Actuator Origin Japan is sponsored by JETRO and co-organized with JETRO, OCCI and OBDA.

Applications are now open for MedTech Actuator Origin Australia 2022 

Do you have an idea, project or innovation in human health? Located in Australia? Find out more about MedTech Actuator Origin and apply today.

Stay in the loop by signing up for news and updates below.

You can also follow us on LinkedIn, Twitter, Facebook and Instagram to keep up to date with the latest events and programs.




Announcing MedTech Actuator’s first Origin Japan cohort

MedTech Actuator is proud to announce its early-stage innovation program, MedTech Actuator Origin Japan 2022, launching next week.

This program supports health innovation across Japan, offering emerging founders and entrepreneurs the opportunity to explore the Asia-Pacific market for the commercialisation of health innovation. 

The selected top 14 Japanese MedTech, BioTech and HealthTech entrepreneurs will start the program with MedTech Actuator, JETRO (Japanese External Trade Organisation), OCCI (Osaka Chamber of Commerce and Industry), OBDA (Osaka Business Development Agency) and industry experts from across Japan and Australia, at a 3-day bootcamp in Osaka next week. Together, they will learn about the Asia-Pacific ecosystem, pathways to market, startup investment cycles, strategic partnerships and attend a series of pitching workshops before pitching for their chance to travel to Australia to join MedTech Actuator Origin.

Welcoming Origin Japan participants

We are excited to announce the 14 teams selected to participate in the MedTech Actuator Origin Japan 2022 Program. 

  • Smart Tissues Co., Ltd. | Kohei Katsurasako, Denise Zujur | Smart Tissues Co. is developing the first antibacterial and universal bioink for bioprinting human living tissues and organs.
  • Osaka Heat Cool (Thermo Scratch) | Kenzo Ibano | Osaka Heat Cool helps to tackle the symptoms of Atopic Dermatitis(AD), allergies, and other skin diseases by stopping itchiness using thermal illusion on the skin.
  • Second Heart project | Yukihiro Ishida | Second Heart project is developing a healthcare device that allows easy observation of the feet in the home to prevent amputation due to diabetes.
  • Medical Shinansha | Kosuke Sasai | Medical Shinansha provides a suite of diagnostic imaging innovations that support clinician navigation and student training to lead to more efficient clinical management, improved patient satisfaction, and better clinical capacity for accurate diagnosis.
  • Chinougijutsu Co., Ltd. | Ryoji Otsu, Seiichi Hayashi |  Chinougijutsu Co. has jointly developed an artificial intelligence system that prevents falls in hospitals and aged-care settings.
  • RealVision | Gajanan Revankar | A digital therapeutic and diagnostic tool for neurodegenerative diseases that improves diagnosis, prognosis, and long-term disease management.
  • PMCODE Co., Ltd. | Tatsuya ONODA, Masatoshi Taketani | A hybrid information storage symbol mark technology for patient-driven healthcare information management.
  • Tombo™ Systems KK | Ross K. Purdie, Michael Clemons | The Tombo is a certified non-exercise, thermo-genesis activity device that prevents the onset of deep vein thrombosis from sitting at a chair or in front of a computer for a long period of time.
  • MediGear International Corporation | Takeo Tanaka |  A drug-free tumour-targeted minimally invasive therapy” that obtains an antitumor effect without a drug by blocking the supply of oxygen and nutrients to cancer cells by locally administering a uniquely developed nanodevice to the tumour and specifically surrounding the tumour as a barrier.
  • Relive (CureMind) | Risa Kaneda | CureMind is an online, high-availability, real-time access to cancer support services in a safe environment via a mobile application.
  • Kyocare | Hiba Abuelgasim Fadlelmoula Abdelrahman | A digital platform connecting families with elderly relations in need of care to care workers from their local community.
  • Mu Ltd. (MiniMermaid) | Naotake Ohtsuka, Hirosuke Tomozoe |  Mu is developing Minimermaid, a self-propelled capsule endoscopy for the examination of digestive tract cancer without pain.
  • Redge, inc. | ​​Takahiro Hirayama | Redge is developing CeTrax, a medical device management and education system that leverages Japanese clinical engineering technology to address the lack of reliable information and training.
  • iDevice, Inc. | Yuto Kido |  iDevice has created the Javalla mask – a tailor-made ventilation mask that provides comfortable sealing and prevents skin injuries and discomfort.

Congratulations to the qualifying teams. We wish them all the best with their pitches at the Origin Japan semi-final on Wednesday.

Next, the 3 qualifying teams from Japan will join MedTech Actuator in Melbourne in October where over five days they’ll learn from industry experts, pressure test their innovations, and network with and pitch to Australia’s startup ecosystem. 

Ultimately, one Japanese startup will be selected to return to Australia to pitch at the MedTech Actuator Showcase 2022 – an industry event attended by 300 experts in health innovation on December 1. At this event, startups will compete for a chance to win a $10K cash prize, over $5k worth of in-kind support, and a fast-tracked entry into MedTech Actuator Accelerator 2023  to catalyse the commercialisation of their ideas.

MedTech Actuator Origin Japan is sponsored by JETRO and co-organized with JETRO, OCCI and OBDA.

Applications are now open for MedTech Actuator Origin Australia 2022 

Do you have an idea, project or innovation in human health? Located in Australia? Find out more about MedTech Actuator Origin and apply today.

Stay in the loop by signing up for news and updates below.

You can also follow us on LinkedIn, Twitter, Facebook and Instagram to keep up to date with the latest events and programs.